Table 2.
Blood routine examination and Chest CT scan findings of hemodialysis patients with COVID-19
| Characteristics | Total (N = 32) | Diabetes (N = 16) | Non-diabetes (N = 16) | P value |
|---|---|---|---|---|
| Blood routine | ||||
| Leucocytes (*109/L), median (range) | 5.08 (2.74–9.43) | 6.45 (3.55–7.99) | 4.53 (2.74–9.43) | 0.6 |
| Normal range | 3.5–9.5 | |||
| Neutrophils (*109/L), median (range) | 3.82 (1.87–7.06) | 4.44 (2.43–6.61) | 3.52 (1.87–7.06) | 0.855 |
| Normal range | 1.8–6.3 | |||
| Lymphocytes (*109/L), median (range) | 0.765 (0.11–1.47) | 0.84 (0.49–1.22) | 0.64 (0.11–1.47) | 0.592 |
| Normal range | 1.1–3.2 | |||
| Hemoglobin (g/L), median (range) | 97 (55–122) | 102 (81–120) | 91 (55–122) | 0.096 |
| Normal range | 130–175 | |||
| Platelets (*109/L), median (range) | 147 (36–332) | 147 (56–332) | 149 (36–310) | 0.89 |
| Normal range | 125–350 | |||
| Chest CT scan findings-no., % | 0.866 | |||
| Ground-glass opacity | 18 (56.25%) | 9 (56.25%) | 9 (56.25%) | |
| Local patchy shadowing | 7 (21.875%) | 3 (18.75%) | 4 (25%) | |
| Bilateral patchy shadowing | 7 (21.875%) | 4 (25%) | 3 (18.75%) |
Covid-19 coronavirus disease 2019